Skip to main content
Figure 2 | Radiation Oncology

Figure 2

From: Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial

Figure 2

Robustness analyses for a representative case. (A) Axial, sagittal, and coronal views of the dose distributions for the nominal and worst-case plans and the difference in dose between them (nominal minus worst-case). The white line represents the contoured clinical target volume (CTV). (B) Dose-volume histogram of the CTV for seven scenarios: the nominal plan and the cold and hot doses on the T0 phase, T50 phase, and 4D accumulated plans. (C) Worst-case dose distributions on the T0 and T50 phases and the differences between them. (D) Banded dose-volume histogram of the CTV. The blue and red solid lines represent the DVHs for the CTV (blue) and the PTV (red) in the nominal plan.

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us